Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-152.15M -95.99M -89.06M -32.61M
Depreciation & Amortization
105K -4.09M -846K 176K
Stock-Based Compensation
20.8M 11.49M 8.89M 3.01M
Other Working Capital
6.11M -5M -3.86M 3.04M
Other Non-Cash Items
-6.1M 2.27M 6.67M 4M
Deferred Income Tax
n/a n/a n/a -1.8M
Change in Working Capital
2.66M -5.87M 6.75M 3.51M
Operating Cash Flow
-134.68M -92.18M -67.6M -23.71M
Capital Expenditures
-972K -63K -62K n/a
Cash Acquisitions
n/a n/a 70.49K 796K
Purchase of Investments
-711.99M -224.93M -148.49M n/a
Sales Maturities Of Investments
278.96M 185.56M 78M n/a
Other Investing Acitivies
8.97M n/a -70.49K -5M
Investing Cash Flow
-425.03M -39.43M -70.55M -4.2M
Debt Repayment
n/a 24.74M 19.82M 4.92M
Common Stock Repurchased
-13K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-25.85M -6.2M -4.01M -2.21M
Financial Cash Flow
606.67M 133.54M 101.93M 53.88M
Net Cash Flow
46.97M 1.93M -36.22M 25.97M
Free Cash Flow
-135.65M -92.24M -67.66M -23.71M